Last edition
News about "Zuellig Pharma"
Zuellig Pharma has acquired rights to Cialis from Eli Lilly and Company in Hong Kong, Macau and South Korea, expanding its ownership of the men’s health drug across 11 Asian markets.
Zuellig Pharma | 16/03/2026 | By News Bureau
Zuellig Pharma Acquires Propan from ADP Pharma in Philippines
The acquisition of Propan marks Zuellig Pharma's continued expansion into consumer healthcare as it strategically innovates its offerings to meet Asia's evolving healthcare needs.
Zuellig Pharma | 07/01/2025 | By Aishwarya | 1082
Zuellig Pharma Signs Exclusive Distribution Deal with Regeneron to Launch Libtayo
Regeneron is a biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases.
Zuellig Pharma | 28/08/2024 | By Aishwarya | 476
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy